Phynart Studio Ideaya Biosciences (IDYA) on Sunday said it selected IDE101 as a drug candidate for further development to treat cancers lacking CDKN2A, a gene that normally helps prevent uncontrolled…
Tag:
Phynart Studio Ideaya Biosciences (IDYA) on Sunday said it selected IDE101 as a drug candidate for further development to treat cancers lacking CDKN2A, a gene that normally helps prevent uncontrolled…
Welcome to AI Investor Picks, your trusted source for investment insights, financial strategies, and business opportunities. We are dedicated to providing cutting-edge information and analysis on a wide range of investment topics, including stocks, cryptocurrency, real estate, finance, and much more.
© 2025 AI Investor Picks – All Rights Reserved